Paper4076233
Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule.
Matzku S and 3 others. Eur J Nucl Med, 1985. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule. Papers, record 4076233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4076233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Iodine Radioisotopes | Major topic |
| Melanoma | Major topic |
| Animals | |
| Antibody Affinity | |
| Binding Sites, Antibody | |
| Humans | |
| Isotope Labeling | |
| Mice | |
| Mice, Nude | |
| Radionuclide Imaging |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30693 | Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. | Immunochemistry | 1978 | https://conductscience.org/library/papers/30693 | PubMed |
| 2 | 6362854 | Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody. | Cancer Res | 1984 | https://conductscience.org/library/papers/6362854 | PubMed |
| 3 | 5432063 | Cleavage of structural proteins during the assembly of the head of bacteriophage T4. | Nature | 1970 | https://conductscience.org/library/papers/5432063 | PubMed |
| 4 | 6086763 | Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. | J Immunol Methods | 1984 | https://conductscience.org/library/papers/6086763 | PubMed |
| 5 | 6556951 | Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6556951 | PubMed |
| 6 | 7033148 | Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. | Int J Cancer | 1981 | https://conductscience.org/library/papers/7033148 | PubMed |
| 7 | 6934537 | Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6934537 | PubMed |
| 9 | 7397697 | Radiolabeling of antibodies. | Cancer Res | 1980 | https://conductscience.org/library/papers/7397697 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19204779 | Factors affecting the antigen-antibody reaction. | Blood Transfus | 2007 | https://conductscience.org/library/papers/19204779 | PubMed |
| 3829049 | Criteria for selecting monoclonal antibodies with respect to accumulation in melanoma tissue. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3829049 | PubMed |
| 3792375 | Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part II. Comparison of immunoreactivity and biodistribution of monoclonal antibodies labeled with the 67Ga-chelate or with 131I. | Eur J Nucl Med | 1986 | https://conductscience.org/library/papers/3792375 | PubMed |
| 3428284 | Comparative tumour localization properties of radiolabelled monoclonal antibody preparations of defined immunoreactivities. | Eur J Nucl Med | 1987 | https://conductscience.org/library/papers/3428284 | PubMed |
| 2383475 | Evaluation of the immunoreactive fraction of an anti-tumour monoclonal antibody. | Br J Cancer Suppl | 1990 | https://conductscience.org/library/papers/2383475 | PubMed |
| 2383472 | Antibody transport and internalization into tumours. | Br J Cancer Suppl | 1990 | https://conductscience.org/library/papers/2383472 | PubMed |
| 1764368 | Radiolocalisation and imaging of stably HPLAP-transfected MO4 tumours with monoclonal antibodies and fragments. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1764368 | PubMed |
| 1637680 | In vivo measurement of the association constant of a radio-labelled monoclonal antibody in experimental immunotargeting. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1637680 | PubMed |
| 1618231 | The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens. | Eur J Nucl Med | 1992 | https://conductscience.org/library/papers/1618231 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4076233
GET https://conductscience.org/api/papers/v1/4076233/authors